- Location
drugmaker
"-
Thin Film Electronics Provides NFC Technology to GSK's OTC Brand Flonase
Oct 10, 2017Thin Film Electronics has provided its near field communication (NFC) technology to British drugmaker GlaxoSmithKline’s (GSK) over-the-counter (OTC) brand Flonase. GSK has deployed Thinfilm’s SpeedTap tags to create ...
-
Pershing Square Sells 20 Million Shares In Mondelez
Mar 18, 2016Pershing Square, a hedge fund run by investor Bill Ackman, has sold 20 million shares of US-based confectionery giant Mondelez International. Following the sale, the investor now owns only a 5.6% of the confectionery company. In a ...
Tags: Pershing Square, Bill Ackman, Mondelez
-
TCM Companies Find Gold in Overseas Markets
Dec 24, 2015Traditional Chinese medicine makers are expanding their presence in the global markets in a big way, as the government reiterated its support to further strengthen the sector. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, the ...
Tags: Traditional Chinese medicine, Overseas Markets, medicine
-
The FDA Has Rejected The New Multiple Sclerosis Drug Lemtrada
Jan 6, 2014The FDA has rejected the new multiple sclerosis drug Lemtrada, saying the drugmaker didn't show the drug's benefits outweigh some serious risks. The agency asked the maker, Genzyme, to test the drug in more clinical trials. The drug was ...
Tags: FDA, Lemtrada, Genzyme, relapsing-remitting MS, rejection
-
FDA Approved Sunovion AED Aptiom for The Treatment of Partial-Onset Seizures in Patients
Nov 12, 2013The US Food and Drug Administration (FDA) has approved Sunovion Pharmaceuticals' (Sunovion) antiepileptic drug (AED) Aptiom (eslicarbazepine acetate) for the treatment of partial-onset seizures in patients with epilepsy. According to the ...
Tags: FDA, Sunovion, partial-onset seizure, epilepsy
-
Roche Entered Into a License Agreement with Polyphor for Antibiotic Drug
Nov 6, 2013Swiss drugmaker Roche has entered into a license agreement with Polyphor for the development and commercialization of its investigational macrocycle antibiotic, POL7080, to treat patients suffering from bacterial infections caused by ...
Tags: Roche, Polyphor, Antibiotic Drug
-
EMA Committee for CHMP Has Recommended Marketing Approval for Abilify Maintena
Sep 27, 2013Danish pharmaceutical company H. Lundbeck and Japanese drugmaker Otsuka Pharmaceutical have announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing approval for ...
-
EU's Committee for Medicinal Products for Human Use Has Issued a Positive Opinion
Sep 25, 2013Swiss drugmaker F. Hoffmann-La Roche has announced that the EU’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending authorization of Kadcyla as a single agent for the treatment of adult ...
Tags: Breast Cancer Drug
-
AstraZeneca Has Received Positive Opinion From The Committee for Medicinal Products
Sep 24, 2013British drugmaker AstraZeneca has received positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for its new four-in-one flu vaccine Fluenz Tetra. Fluenz Tetra, a nasally ...
Tags: Astrazeneca, Medicine
-
Unilife Has Won a Contract From French Drugmaker Sanofi to Supply Unifill Finesse
Sep 11, 2013Unilife, a manufacturer of injectable drug delivery systems, has won a contract from French drugmaker Sanofi to supply Unifill Finesse, a customized device from its Unifill platform of prefilled syringes, for use with the anti-thrombotic ...
Tags: Unifill Syringes, Sanofi
-
AVNR Has Entered Into a Settlement Agreement with The US Unit
Sep 10, 2013US-based Avanir Pharmaceuticals (AVNR) has entered into a settlement agreement with the US unit of Indian drugmaker Wockhardt to resolve pending patent litigation in response to Wockhardt's abbreviated new drug application (ANDA) seeking ...
Tags: Avanir Pharma, Medicine
-
Otsuka Pharmaceutical Has Agreed to Acquire Astex Pharmaceuticals for $866m
Sep 9, 2013Japanese drugmaker Otsuka Pharmaceutical has agreed to acquire Astex Pharmaceuticals for $866m in an all-cash tender offer. Under the deal, Astex's fragment-based drug design technology called 'PYRAMID' will be integrated into Otsuka, ...
-
Biocon Is Sure Herceptin Biosimilar Version Will Be Launched This Year
Aug 26, 2013India-based Biocon is likely to launch the Swiss drugmaker Roche's Herceptin (trastuzumab) biosimilar version by the end of 31 March 2014, following the latter's decision to give up a patent fight over the breast cancer drug in the country. ...
-
China Launches Investigation Into Pharma Services Sector
Aug 18, 2013China is intensifying its investigation into alleged bribery in the pharmaceutical and medical services sector with a fresh three-month probe due to begin today. The investigation by the State Administration for Industry and Commerce, a ...
Tags: milk powder, medicine pricing
-
Availability of ONFI in Scored Tablet and Oral Suspension Formulations
Aug 15, 2013Danish drugmaker Lundbeck has announced the availability of ONFI (clobazam) in scored tablet and oral suspension formulations in the US pharmacies beginning this week. ONFI, an oral anti-epileptic drug (AED) of the benzodiazepine class, ...